Axil Capital logo

Axil Capital

Asia, Tokyo, Japan, Tokyo

Description

Axil Capital is a venture capital firm investing in companies in the biomedical and healthcare fields from the early stages.

Investor Profile

Axil Capital has made 7 investments, with 2 in the past 12 months and 14% as lead.

Stage Focus

  • Series B (43%)
  • Series Unknown (29%)
  • Series A (14%)
  • Series C (14%)

Country Focus

  • United States (43%)
  • Israel (29%)
  • Japan (29%)

Industry Focus

  • Health Care
  • Biotechnology
  • Medical
  • Health Diagnostics
  • Pharmaceutical
  • Therapeutics
  • Genetics
  • Biopharma
  • Oncology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Axil Capital frequently co-invest with?

SCREEN Holdings
Asia, Kyoto, Japan, Kyoto
Co-Investments: 1
Taiwania Capital Management Corporation
Asia, T'ai-pei, Taiwan, Taipei
Co-Investments: 3
Johnson & Johnson Innovation – JJDC
North America, Massachusetts, United States, Cambridge
Co-Investments: 2
AT
Asia, Hefa, Israel, Haifa
Co-Investments: 1
Cobro Ventures
North America, Virginia, United States, Arlington
Co-Investments: 3
RTW Investments
North America, New York, United States, New York
Co-Investments: 2
3E Bioventures
Asia, Beijing, China, Beijing
Co-Investments: 1
Perceptive Advisors
North America, New York, United States, New York
Co-Investments: 2
Co-Investments: 2
NextLeap Ventures
Asia, Tel Aviv, Israel, Herzliya
Co-Investments: 2

What are some of recent deals done by Axil Capital?

Linqmed

Chiba, Chiba, Japan

Linqmed is a pharmaceutical company that specializes in the research and development of radiopharmaceuticals for cancer treatment.

Health CareHealth DiagnosticsMedicalOncologyPharmaceutical
Series BJan 10, 2025
Amount Raised: $9,512,632
MabGenesis

Yokohama, Kanagawa, Japan

MabGenesis is a biotechnology firm that provides therapeutic monoclonal antibody drugs.

BiopharmaBiotechnologyHealth CarePharmaceutical
Series UnknownDec 24, 2024
Amount Raised: $2,991,554
Suono Bio

Boxborough, Massachusetts, United States

Suono Bio is a biotechnology company enabling ultra-rapid delivery of novel therapeutics to the gastrointestinal tract.

BiotechnologyHealth CareMedical
Series AMar 29, 2021
TechsoMed

Rehovot, HaMerkaz, Israel

Ultrasound based real-time monitoring systems for thermal ablation procedures

BiotechnologyHealth Care
Series BMar 3, 2021
Amount Raised: $7,000,000
C4 Therapeutics

Cambridge, Massachusetts, United States

C4 Therapeutics develops novel early stage therapies that eliminate disease-causing proteins.

Health DiagnosticsMedicalTherapeutics
Series BJun 16, 2020
Frequency Therapeutics

Lexington, Massachusetts, United States

Frequency Therapeutics develops small molecule drugs that activate progenitor cells within the body to restore healthy tissue.

BiotechnologyGeneticsHealth CareMedical
Series CJul 23, 2019
TechsoMed

Rehovot, HaMerkaz, Israel

Ultrasound based real-time monitoring systems for thermal ablation procedures

BiotechnologyHealth Care
Series UnknownMay 30, 2019
Amount Raised: $2,600,000